RSS
30 Nov 2020

CTI BioPharma Announces Publication of Article Highlighting Pacritinib Data from the PAC203 Phase 2 Study in Myelofibrosis in Blood Advances

Author: admintech | Filed under: Press Release

SEATTLE, Nov. 30, 2020 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) today announced that an article highlighting pacritinib data was published in Blood Advances. The article, titled “Determining the Recommended Dose of Pacritinib: Results from the PAC203 Phase 2 Dose-Finding Study…

This entry was posted on Monday, November 30th, 2020 at 7:10 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»